FDA Advisory Committee To Review Genentech’s Avastin For Use As Breast Cancer Treatment

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Genentech on Thursday announced that an FDA advisory panel in December will review its colon and lung cancer treatment Avastin as a first-line treatment for metastatic breast cancer, [click link for full article]

More: continued here




   Posted in Disease & Illness    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply